MIST – milestone pharmaceuticals inc. - common shares (US:NASDAQ)

News

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jefferies Lifts Milestone Pharmaceuticals (MIST) Price Targets on Product Sales Prospects [Yahoo! Finance]
Milestone Pharmaceuticals (NASDAQ:MIST) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Milestone Pharmaceuticals (NASDAQ:MIST) was upgraded by analysts at Wall
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Shares Could Be 44% Below Their Intrinsic Value Estimate [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com